Sedivention

Devices for therapy and prevention

Invented in Bavaria

Our Partners and Supporters

We work internationally with experts in engineering, regulatory, and clinical.

Medicine is our passion

With a long and intense experience in clinical practise, we know where the medical need is.
With our devices, we aim to address these needs and make therapy less invasive.

Ute Nollert, MD, founder of Sedivention experienced the whole spectrum of anesthesiology from liver transplant and ICU to cardiac surgery and dental interventions. The setting was international from university hospitals to ambulatory care.

The Team

André Burch MSc, EMBA

28+ years in global leading medical device companies

•Board of Directors, VP Finance & Admin at BIOTRONIK Vascular Intervention

•VP Clinical/Regulatory Affairs, VP New Businesses (startup approach)

•Director R&D at BIOTRONIK VI

•Director R&D, Boston Scientific and Pfizer/Schneider Worldwide

•ETH Zurich / IMD Lausanne, Switzerland

Ute Nollert, MD

•Consultant in anaesthesia at the University of Munich, LMU for 13 years

•European Diploma in Anaesthesiology and Intensive Care

•Author o f numerous scientific articles and textbook chapters in particular ambulant anesthesia and conscious sedation

Consultant Sana Klinik, Munich, Germany

Stéphane Delaloye,
PhD, EMBA

25+ years in medical device industry, numerous key patents granted

•COO/VP R&D, Symetis AG – from start to successful exit in 2017

•Director R&D, Biotronik AG

•Manager R&D, Boston Scientific

•Manager R&D, Pfizer/Schneider WW

ETH Zurich / HSG St. Gallen, Switzerland